254 related articles for article (PubMed ID: 35326884)
1. Mechanisms of Action of Carbapenem Resistance.
Aurilio C; Sansone P; Barbarisi M; Pota V; Giaccari LG; Coppolino F; Barbarisi A; Passavanti MB; Pace MC
Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326884
[TBL] [Abstract][Full Text] [Related]
2. [MULTIRESISTANT BACTERIA].
Bedenić B; Sardelić S; Ladavac M
Acta Med Croatica; 2015 Sep; 69(3):211-6. PubMed ID: 29077379
[TBL] [Abstract][Full Text] [Related]
3. Class D β-lactamases: a reappraisal after five decades.
Leonard DA; Bonomo RA; Powers RA
Acc Chem Res; 2013 Nov; 46(11):2407-15. PubMed ID: 23902256
[TBL] [Abstract][Full Text] [Related]
4. The KPC type beta-lactamases: new enzymes that confer resistance to carbapenems in Gram-negative bacilli.
Sacha P; Ostas A; Jaworowska J; Wieczorek P; Ojdana D; Ratajczak J; Tryniszewska E
Folia Histochem Cytobiol; 2009; 47(4):537-43. PubMed ID: 20430717
[TBL] [Abstract][Full Text] [Related]
5. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of resistance to beta-lactam antibiotics.
Livermore DM
Scand J Infect Dis Suppl; 1991; 78():7-16. PubMed ID: 1947825
[TBL] [Abstract][Full Text] [Related]
7. Activity of the β-Lactamase Inhibitor LN-1-255 against Carbapenem-Hydrolyzing Class D β-Lactamases from Acinetobacter baumannii.
Vázquez-Ucha JC; Maneiro M; Martínez-Guitián M; Buynak J; Bethel CR; Bonomo RA; Bou G; Poza M; González-Bello C; Beceiro A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807908
[TBL] [Abstract][Full Text] [Related]
8. Expanded Substrate Activity of OXA-24/40 in Carbapenem-Resistant Acinetobacter baumannii Involves Enhanced Binding Loop Flexibility.
Staude MW; Leonard DA; Peng JW
Biochemistry; 2016 Nov; 55(47):6535-6544. PubMed ID: 27783477
[TBL] [Abstract][Full Text] [Related]
9. [Pseudomonas aeruginosa--a significant hospital pathogen and resistance to carbapenem].
Kucisec-Tepes N
Acta Med Croatica; 2004; 58(4):313-21. PubMed ID: 15700688
[TBL] [Abstract][Full Text] [Related]
10. Bench-to-bedside review: The role of beta-lactamases in antibiotic-resistant Gram-negative infections.
Bush K
Crit Care; 2010; 14(3):224. PubMed ID: 20594363
[TBL] [Abstract][Full Text] [Related]
11. Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Martínez-Martínez L; González-López JJ
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():4-9. PubMed ID: 25542046
[TBL] [Abstract][Full Text] [Related]
12. Direct medical costs of urinary tract infections by Gram-negative bacilli resistant to beta-lactams in a tertiary care hospital in Medellín, Colombia.
Vargas-Alzate CA; Higuita-Gutiérrez LF; Jiménez-Quiceno JN
Biomedica; 2019 May; 39(s1):35-49. PubMed ID: 31529847
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic inactivation of bacterial carbapenemases restores bacterial carbapenem susceptibility and enhances carbapenem antibiotic effectiveness.
Feng Y; Palanisami A; Ashraf S; Bhayana B; Hasan T
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101693. PubMed ID: 32173586
[TBL] [Abstract][Full Text] [Related]
14. Bacterial resistance to carbapenems.
Livermore DM
Adv Exp Med Biol; 1995; 390():25-47. PubMed ID: 8718600
[TBL] [Abstract][Full Text] [Related]
15. Genetic diversity and risk factors for the transmission of antimicrobial resistance across human, animals and environmental compartments in East Africa: a review.
Katale BZ; Misinzo G; Mshana SE; Chiyangi H; Campino S; Clark TG; Good L; Rweyemamu MM; Matee MI
Antimicrob Resist Infect Control; 2020 Aug; 9(1):127. PubMed ID: 32762743
[TBL] [Abstract][Full Text] [Related]
16. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
Thomson JM; Bonomo RA
Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
[TBL] [Abstract][Full Text] [Related]
17. Decoding the Structural Basis For Carbapenem Hydrolysis By Class A β-lactamases: Fishing For A Pharmacophore.
Tondi D; Cross S; Venturelli A; Costi MP; Cruciani G; Spyrakis F
Curr Drug Targets; 2016; 17(9):983-1005. PubMed ID: 26424401
[TBL] [Abstract][Full Text] [Related]
18. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
Spera AM; Esposito S; Pagliano P
Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
[TBL] [Abstract][Full Text] [Related]
19. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
Neu HC
Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]